These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24731551)

  • 1. [Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].
    Arbizu J; Luquin MR; Abella J; de la Fuente-Fernández R; Fernandez-Torrón R; García-Solís D; Garrastachu P; Jiménez-Hoyuela JM; Llaneza M; Lomeña F; Lorenzo-Bosquet C; Martí MJ; Martinez-Castrillo JC; Mir P; Mitjavila M; Ruiz-Martínez J; Vela L
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):215-26. PubMed ID: 24731551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional neuroimaging with SPECT in Parkinson's disease and Parkinsonisms].
    Lorenzo-Bosquet C; Hernández-Vara J; Castell-Conesa J; Miquel-Rodríguez F
    Rev Neurol; 2008 Apr 1-15; 46(7):430-5. PubMed ID: 18389463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.
    Thobois S; Prange S; Scheiber C; Broussolle E
    Parkinsonism Relat Disord; 2019 Feb; 59():93-100. PubMed ID: 30181086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging in Parkinsonian Disorders.
    Tripathi M; Kumar A; Bal C
    Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.
    Horowitz T; Grimaldi S; Azulay JP; Guedj E
    Rev Neurol (Paris); 2022 May; 178(5):484-489. PubMed ID: 35527085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.
    Buchert R; Buhmann C; Apostolova I; Meyer PT; Gallinat J
    Dtsch Arztebl Int; 2019 Nov; 116(44):747-754. PubMed ID: 31774054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Molecular Imaging in Atypical Parkinsonism.
    Xu Z; Arbizu J; Pavese N
    Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of molecular imaging in assessing degenerative parkinsonism - an updated review.
    Nicastro N; Garibotto V; Burkhard PR
    Swiss Med Wkly; 2018; 148():w14621. PubMed ID: 29698545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis.
    Meyer PT; Hellwig S
    Curr Opin Neurol; 2014 Aug; 27(4):390-7. PubMed ID: 24950013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in Movement Disorders.
    Maiti B; Perlmutter JS
    Continuum (Minneap Minn); 2023 Feb; 29(1):194-218. PubMed ID: 36795878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice.
    Poewe W; Scherfler C
    Mov Disord; 2003 Oct; 18 Suppl 7():S16-21. PubMed ID: 14531041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional imaging in movement disorders].
    Swiat M; Opala G; Jasińska-Myga B
    Neurol Neurochir Pol; 2006; 40(1):42-50. PubMed ID: 16463221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radionuclide techniques in the diagnosis of parkinsonian syndromes].
    Pöpperl G; Tatsch K
    MMW Fortschr Med; 2004 Mar; 146(10):24-6. PubMed ID: 15347073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
    Vaamonde J; Ibáñez R; García AM; Poblete V
    Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in Parkinson's Disease: necessity or exaggeration?
    Śmiłowska K; Burzyńska-Makuch M; Brockhuis B; Piekarski R; Friedman A; Popek A; Sławek J
    Neurol Neurochir Pol; 2021; 55(6):536-548. PubMed ID: 34637136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.